Search clinical trials for: 18f-Fluoride PET/CT scan

Total 2920 results

University of Edinburgh
NHS Lothian; British Heart Foundation

Completed

Metabolic Imaging in Carotid Atherosclerosis (MICA)

Stroke | Atherosclerosis

United Kingdom
The Methodist Hospital Research Institute
University of California, Los Angeles

Terminated

Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma

Glioma | Glioblastoma | Glioblastoma Multiforme

United States
Columbia University

Active, not recruiting

18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer

Prostatic Neoplasms

United States
University of Utah

Recruiting

[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma

Invasive Lobular Breast Carcinoma

United States
Peking Union Medical College Hospital

Recruiting

Characterizing Breast Cancer With 18F-FES PET/CT

Breast Cancer

China
Memorial Sloan Kettering Cancer Center

Completed

Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients

Head and Neck Cancer

United States
Rigshospitalet, Denmark
Herlev Hospital

Active, not recruiting

Diagnosis of Bone Metabolism in Patients With Inexplicable Lower Back Pain

Lower Back Pain Chronic

Denmark
Lawson Health Research Institute
Ontario Institute for Cancer Research

Completed

Advanced Prostate Imaging of Recurrent Cancer After Radiotherapy (PICs)

Prostate Cancer

Canada
Amsterdam UMC, location VUmc

Completed

FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET (FORESIGHT)

Breast Cancer

Netherlands
Institut Cancerologie de l'Ouest
SIRIC ILIAD

Completed

[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers (EITHICS)

Triple Negative Breast Cancer

France
GE Healthcare
Laboratory Corporation of America

Not yet recruiting

Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Trevarx Biomedical, Inc

Suspended

A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer

Breast Carcinoma

United States
National Cancer Institute (NCI)

Completed

Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1

Neurofibromatosis | MPNST

United States
Nottingham University Hospitals NHS Trust

Completed

[18F]HX4 PET/CT Imaging for Detection of Hypoxia (OXYPET)

Head and Neck Cancer | Lung Cancer

United Kingdom
Leiden University Medical Center

Recruiting

PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas

Urothelial Carcinoma | Sarcoma,Soft Tissue

Netherlands
Nantes University Hospital

Completed

Assessment of Osteoblastic Activity With 18F-Fluoride in Aortic Bioprosthesis Structural Valve Dysfunction (SVD) (TEP-SVD)

Aortic Bioprosthesis Structural Valve Dysfunction

France
British Columbia Cancer Agency

Recruiting

PSMA PET/CT for Assessment of Recurrent Prostate Cancer

Prostatic Neoplasms | Prostate Cancer

Canada
Erik Mittra
National Cancer Institute (NCI)

Terminated

18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas

Untreated Childhood Brain Stem Glioma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Oligodendroglioma | Adult Pilocytic Astrocytoma | Adult Pineal Gland Astrocytoma and other conditions

United States
Peking University Cancer Hospital & Institute

Recruiting

Research for the Molecular Imaging of the HER2 Targeting Tracer

HER2 Positive or Suspicious Positive Tumors

China
Memorial Sloan Kettering Cancer Center

Recruiting

Imaging With a PET Agent for Detection of Cancers of the Head and Neck

Head and Neck Cancer

United States
Memorial Sloan Kettering Cancer Center

Withdrawn

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

Histologically-confirmed Malignancies

United States
Lawson Health Research Institute
Cancer Care Ontario; Centre for Probe Development and Commercialization

Recruiting

PSMA-PET Registry for Recurrent Prostate Cancer (PREP)

Recurrent Prostate Cancer

Canada
University of Edinburgh

Completed

Assessment of Risk in Thoracic Aortopathy Using 18F-Sodium Fluoride (AoRTAS)

Bicuspid Aortic Valve | Aortic Dissection | Thoracic Aortic Aneurysm

United Kingdom
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer

Prostate Carcinoma

United States
University of Wisconsin, Madison
Millennium Pharmaceuticals, Inc.

Terminated

NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis

Prostatic Neoplasms | Prostate Cancer

United States
Queen's Medical Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer

Hormone Refractory Prostate Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer

Differentiated Thyroid Gland Carcinoma | Thyroid Gland Follicular Carcinoma | Thyroid Gland Papillary Carcinoma

United States
London Health Sciences Centre

Completed

Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI

Rectal Cancer

Canada
GE Healthcare

Recruiting

A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies

Oncology | Malignant Solid Tumor

Netherlands
Cedars-Sinai Medical Center

Completed

18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques

Coronary Artery Disease | Atherosclerotic Plaque

United States
Radboud University Medical Center
University Medical Center Groningen; Haukeland University Hospital; Academisch...

Unknown

FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment (FESPET)

Endometrial Cancer
University Hospital Bispebjerg and Frederiksberg

Completed

Bone Metabolic Activity in the Patellofemoral Joint in Patients With Unilateral PFP

Patellofemoral Pain Syndrome | Anterior Knee Pain Syndrome

Denmark
Peking Union Medical College Hospital

Recruiting

Clinical Study of [18F] PM-PBB3 PET Imaging of Tau Protein in Neurodegenerative Diseases

Neurodegenerative Diseases

China
GE Healthcare
PPD; Fortrea

Not yet recruiting

A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers

Healthy Volunteers

United States
prof. dr. Koen Van Laere
Universitaire Ziekenhuizen KU Leuven; KU Leuven; University Hospital, Ghent; Fund...

Not yet recruiting

[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DBL vs. AD

Parkinson Disease | Alzheimer Disease | Dementia With Lewy Bodies | MSA - Multiple System Atrophy

Belgium
Andrei Iagaru

No longer available

F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer

Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | PSA Progression | PSA Level Greater Than or Equal to Two | PSA Level Greater Than 0.2

United States
Assistance Publique Hopitaux De Marseille

Terminated

Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study

Breast Carcinoma

France
VA Greater Los Angeles Healthcare System
Lantheus Medical Imaging

Not yet recruiting

PSMA PET Scan and mpMRI for Prostate Cancer Detection

Prostate Cancer Diagnosis

United States
University of Arizona
Blue Earth Diagnostics; Banner University Medical Center

Completed

Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma (BoneMetPETCT)

Prostate Adenocarcinoma

United States
Lioe-Fee de Geus-Oei, MD PhD
Amsterdam UMC, location VUmc; The Netherlands Cancer Institute; Centre for Human...

Terminated

[18F]Fluoro-PEG-folate PET/CT Imaging in Epithelial Ovarian Cancer

Epithelial Ovarian Cancer

Netherlands
OHSU Knight Cancer Institute
Oregon Health and Science University; Progenics Pharmaceuticals, Inc.

Not yet recruiting

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Prostate Adenocarcinoma | Castration Resistant Prostate Cancer | Castration Sensitive Prostate Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Breast Carcinoma | Fallopian Tube Carcinoma | Ovarian Carcinoma | Primary Peritoneal Carcinoma | Solid Neoplasm

United States
University of Washington
National Cancer Institute (NCI)

Withdrawn

Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer

Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

Malignant Solid Neoplasm | Malignant Breast Neoplasm | Malignant Pancreatic Neoplasm | Malignant Colorectal Neoplasm

United States
University Hospitals Cleveland Medical Center

Completed

Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer Patients

Prostate Cancer

United States
Radboud University Medical Center
UMC Utrecht; Amsterdam UMC, location VUmc; St. Antonius Hospital; Dijklander Ziekenhuis and other collaborators

Recruiting

The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients (NVALT31-PET)

Stage III Non-small Cell Lung Cancer

Netherlands
Columbia University

Active, not recruiting

Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers

Metastatic Prostate Cancer

United States
Jonsson Comprehensive Cancer Center

Terminated

18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After Interventions

Malignant Neoplasm

United States
Ohio State University Comprehensive Cancer Center

Completed

Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
M.D. Anderson Cancer Center

Completed

An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer

Biochemically Recurrent Prostate Carcinoma | Prostate Adenocarcinoma | Localized Prostate Carcinoma

United States

Search clinical trials for: 18f-Fluoride PET/CT scan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations